Moolec Science (MLEC) Share-based Compensation (2022 - 2025)

Moolec Science (MLEC) reported Share-based Compensation of $7.3 million for Q4 2025, up 258.21% on a YoY basis from $2.0 million in Q4 2024, and little changed sequentially from $7.3 million in Q2 2025.

Moolec Science (MLEC) Share-based Compensation (2022 - 2025) Analysis & Trends

Moolec Science (MLEC) has 4 years of Share-based Compensation data on file, last reported at $7.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 258.21% year-over-year to $7.3 million; the trailing twelve-month figure through Dec 2025 stood at $7.3 million (up 258.21% YoY), and the FY2025 full-year result was $7.3 million, down 48.79% from the prior year.
  • Share-based Compensation was little changed at $7.3 million in Q4 2025, from $7.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $15.9 million in Q2 2024 to a low of $63876.0 in Q2 2022.
  • A 4-year average of $3.6 million and a median of $2.2 million in 2023 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation jumped 5227.35% in 2023 and tumbled 54.3% in 2025, its largest moves.
  • Tracing MLEC's Share-based Compensation over 4 years: stood at $551841.0 in 2022, then soared by 298.92% to $2.2 million in 2023, then slipped by 7.34% to $2.0 million in 2024, then jumped by 258.21% to $7.3 million in 2025.
  • Business Quant data shows MLEC's Share-based Compensation at $7.3 million in Q4 2025, $7.3 million in Q2 2025, and $2.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 66,981.90 Bn 66,981.62 Bn - 6.39 Mn
2 Nanobiotix 1,913.50 Bn 1,913.44 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 305,000.00
4 BeOne Medicines 472.03 Bn 467.24 Bn 1.35 Bn 9.26 Mn
5 Vertex Pharmaceuticals 122.09 Bn 114.84 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 70.01 Bn 61.26 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.34 Bn 62.34 Bn - -
8 Argenx Se 55.99 Bn 50.80 Bn 1.41 Bn -
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn -
10 Moolec Science 5.35 Bn 5.35 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 7.31 Mn
Dec 31, 2025 7.31 Mn
Jun 30, 2025 7.27 Mn
Jun 30, 2025 7.27 Mn
Dec 31, 2024 2.04 Mn
Dec 31, 2024 2.04 Mn
Sep 30, 2024 3.67 Mn
Sep 30, 2024 3.67 Mn
Jun 30, 2024 15.91 Mn
Jun 30, 2024 15.91 Mn
Mar 31, 2024 2.97 Mn
Mar 31, 2024 2.97 Mn
Dec 31, 2023 2.20 Mn
Dec 31, 2023 2.20 Mn
Sep 30, 2023 1.74 Mn
Sep 30, 2023 1.74 Mn
Jun 30, 2023 3.40 Mn
Jun 30, 2023 3.40 Mn
Mar 31, 2023 154,235.00
Mar 31, 2023 154,235.00